Craft

BioMaxima

Stock Price

ZŁ14.6

2024-10-29

Market Capitalization

ZŁ61.2 M

2024-10-29

Revenue

ZŁ60.9 M

FY, 2025

BioMaxima Summary

Company Summary

Overview
BioMaxima is a company that produces microbiology media, reagents, and in vitro diagnostics equipment. It offers urine analysis systems, ion selective analyzers, glucose meters, hematological reagents, rapid diagnostic tests, and other products. The company caters to clinical, veterinary, and industrial diagnostics markets.
Type
Public
Status
Active
Founded
1997
Website
https://www.biomaxima.com
Cybersecurity rating
Sectors

Table of Contents

BioMaxima Financials

Summary Financials

Revenue (FY, 2025)
zł60.9M
Gross profit (FY, 2025)
zł23.2M
Net income (FY, 2025)
zł105.0K
Cash (FY, 2025)
zł1.7M
EBIT (FY, 2025)
zł1.1M
Enterprise value
$73.9M

Footer menu